Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$900K Sell
7,612
-1,912
-20% -$221K ﹤0.01% 784
2026
Q1
$1.14M Sell
9,524
-8,924
-48% -$1.17M 0.01% 615
2025
Q4
$2.51M Buy
+18,448
New +$2.65M 0.01% 398
2025
Q2
$21.7M Buy
167,411
+1,311
+0.8% +$159K 0.14% 118
2025
Q1
$19.8M Buy
166,100
+12,557
+8% +$1.56M 0.16% 110
2024
Q4
$17.8M Sell
153,543
-7,046
-4% -$891K 0.15% 112
2024
Q3
$21.7M Buy
160,589
+16,301
+11% +$2.18M 0.19% 101
2024
Q2
$19.6M Buy
+144,288
New +$19.6M 0.21% 91
2020
Q1
Sell
-2,750
Closed -$217K 437
2019
Q4
$217K Sell
2,750
-1,187
-30% -$92.4K 0.01% 380
2019
Q3
$313K Buy
3,937
+474
+14% +$37.2K 0.02% 272
2019
Q2
$290K Buy
+3,463
New +$276K 0.02% 244

Other funds holding XYL

EP Wealth Advisors's XYL Position: Q2 2026 in Review

EP Wealth Advisors reduced its Xylem (XYL) stake by 20% in Q2 2026, selling an estimated $221K and leaving 7,612 shares worth $900K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

EP Wealth Advisors first reported a position in XYL in Q2 2019 and has held it in 11 quarters since. The position peaked at $21.7M in Q3 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • EP Wealth Advisors held 7,612 shares of Xylem worth $900K as of Q2 2026.
  • EP Wealth Advisors sold 1,912 Xylem shares in Q2 2026, an estimated $221K.
  • Xylem made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #784 holding.
  • EP Wealth Advisors first reported a position in Xylem in Q2 2019 and has held it in 11 quarters since.
  • EP Wealth Advisors's Xylem position peaked at $21.7M in Q3 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.